ArticleFrontiers in oncology2025

Prognostic role of inflammatory and tumor biomarkers in hilar cholangiocarcinoma patients receiving postoperative adjuvant therapy.

Di Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.